Legal & General Group’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.89M Buy
159,573
+23,716
+17% +$1.02M ﹤0.01% 1384
2025
Q1
$4.7M Buy
135,857
+1,819
+1% +$62.9K ﹤0.01% 1557
2024
Q4
$3.68M Buy
134,038
+14,327
+12% +$393K ﹤0.01% 1727
2024
Q3
$3.05M Sell
119,711
-38,511
-24% -$980K ﹤0.01% 1802
2024
Q2
$4.01M Buy
158,222
+1,235
+0.8% +$31.3K ﹤0.01% 1633
2024
Q1
$4.85M Buy
156,987
+60,022
+62% +$1.86M ﹤0.01% 1532
2023
Q4
$3.91M Buy
96,965
+4,238
+5% +$171K ﹤0.01% 1642
2023
Q3
$2.45M Sell
92,727
-758
-0.8% -$20K ﹤0.01% 1806
2023
Q2
$1.61M Buy
93,485
+6,928
+8% +$119K ﹤0.01% 2017
2023
Q1
$1.44M Buy
86,557
+3,479
+4% +$57.7K ﹤0.01% 2025
2022
Q4
$633K Buy
83,078
+1,049
+1% +$7.99K ﹤0.01% 2279
2022
Q3
$816K Sell
82,029
-26,246
-24% -$261K ﹤0.01% 2208
2022
Q2
$983K Buy
108,275
+23,511
+28% +$213K ﹤0.01% 2163
2022
Q1
$861K Sell
84,764
-1,017
-1% -$10.3K ﹤0.01% 2268
2021
Q4
$1.43M Buy
85,781
+5,991
+8% +$99.9K ﹤0.01% 2144
2021
Q3
$3.74M Buy
79,790
+13,140
+20% +$616K ﹤0.01% 1707
2021
Q2
$4.06M Buy
66,650
+7,148
+12% +$436K ﹤0.01% 1646
2021
Q1
$3.67M Buy
59,502
+10,270
+21% +$633K ﹤0.01% 1725
2020
Q4
$3.5M Buy
49,232
+7,657
+18% +$545K ﹤0.01% 1657
2020
Q3
$1.56M Buy
41,575
+23,434
+129% +$879K ﹤0.01% 1876
2020
Q2
$590K Buy
18,141
+6,660
+58% +$217K ﹤0.01% 2128
2020
Q1
$310K Buy
11,481
+7,036
+158% +$190K ﹤0.01% 2190
2019
Q4
$156K Buy
4,445
+731
+20% +$25.7K ﹤0.01% 2460
2019
Q3
$80K Buy
3,714
+3,658
+6,532% +$78.8K ﹤0.01% 2595
2019
Q2
$2K Buy
+56
New +$2K ﹤0.01% 3478